Mitchell E. Reff — 24 Patents at Idec Pharmaceuticals

Mitchell E. Reff has been granted 24 US patents while listed as an inventor at Idec Pharmaceuticals. The first was granted in 1997 and the most recent in December 2013. Mitchell E. Reff ranks #168,038 of 4,157,543 US inventors in our database (top 4.0%). Patent records list Mitchell E. Reff in San Diego, CA, US.

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
8603473	Modified binding molecules comprising connecting peptides	Scott Glaser, Tzung-Horng Yang, Xiufeng Wu, Paul Chinn	2013-12-10
7744877	Expression and use of anti-CD20 Antibodies	Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter	2010-06-29	$65,858,000
7695940	Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics	William Kloetzer, Takehiko Nakamura	2010-04-13
7452534	Recombinant anti-CD4 antibodies for human therapy	Nabil Hanna, Roland A. Newman	2008-11-18	$159,596,000
7438906	Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics	William Kloetzer, Takehiko Nakamura	2008-10-21
7422739	Anti-CD20 antibodies	Darrell R. Anderson, Nabil Hanna, Roland A. Newman, William H. Rastetter	2008-09-09
7381560	Expression and use of anti-CD20 antibodies	Darrell R. Anderson, Nabil Hanna, Roland A. Newman, William H. Rastetter	2008-06-03	$186,747,000
7338658	Recombinant anti-CD4 antibodies for human therapy	Nabil Hanna, Roland A. Newman	2008-03-04
7332163	Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics	William Kloetzer, Takehiko Nakamura	2008-02-19	$177,447,000
7223392	Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics	William Kloetzer, Takehiko Nakamura	2007-05-29
7033589	γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics	William Kloetzer, Takehiko Nakamura	2006-04-25
6893636	Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics	William Kloetzer, Takehiko Nakamura	2005-05-17
6682734	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma	Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter	2004-01-27	$115,892,000
6399061	Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma	Darrell R. Anderson, Nabil Hanna, Roland A. Newman, William H. Rastetter	2002-06-04
6159730	Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same	—	2000-12-12
6136310	Recombinant anti-CD4 antibodies for human therapy	Nabil Hanna, Roland A. Newman	2000-10-24	$203,936,000
6017733	Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same	—	2000-01-25	$106,603,000
6011138	Gamma-1 anti-human CD23 monoclonal antibodies	William Kloetzer, Takehiko Nakamura	2000-01-04	$74,701,000
5843439	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma	Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter	1998-12-01
5830698	Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same	Richard S. Barnett, Karen McLachlan	1998-11-03	$9,059,000
5776456	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma	Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter	1998-07-07	$5,875,000
5736137	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma	Darrell R. Anderson, Nabil Hanna, John Leonard, Roland A. Newman, William H. Rastetter	1998-04-07	$11,503,000
5733779	Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same	—	1998-03-31	$11,907,000
5648267	Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same	—	1997-07-15	$7,793,000

Mitchell E. Reff — 24 Patents

Issued Patents All Time

Patent Widget